Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Internal Medicine | Pharmacy | Psychiatry | Urology | Journal

Back to Journal Articles

Testosterone Gel Ups Sexual Function in Hypogonadism

Last Updated: August 19, 2011.

 

Topical application of 1 percent testosterone gel increases total and free testosterone levels

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Testosterone replacement therapy with Testim (testosterone 1 percent) topical gel for 12 months significantly increases total testosterone, free testosterone, and total brief male sexual function inventory score in men with hypogonadism, according to a study published online Aug. 11 in The Journal of Sexual Medicine.

FRIDAY, Aug. 19 (HealthDay News) -- Testosterone replacement therapy (TRT) with Testim (testosterone 1 percent) topical gel for 12 months significantly increases total testosterone (TT), free testosterone (FT), and total brief male sexual function inventory (BMSFI) score in men with hypogonadism, according to a study published online Aug. 11 in The Journal of Sexual Medicine.

Mohit Khera, M.D., M.B.A., M.P.H., from the Baylor College of Medicine in Houston, and colleagues examined whether a 12-month treatment regimen with testosterone gel improves sexual function in men with hypogonadism and in subgroups defined by low testosterone, phosphodiesterase type 5 inhibitor use, and prior TRT. Improvement in sexual function was measured by the BMSFI. A total of 271 men with hypogonadism, whose baseline testosterone and BMSFI measurements were available, were selected from the Testim Registry in the United States (TRiUS), treated with Testim topical gel, and followed for 12 months. Measurement of TT, FT, and BMSFI, and physical exam and body measurements were the main outcome measures at one, three, six, and 12 months.

The investigators found that, compared to baseline, a significant increase occurred in average TT and FT levels at 12 months of TRT. At 12 months, there was a significant increase in mean total BMSFI score from baseline, and at each visit the mean total BMSFI score significantly increased from baseline, overall and in all subgroups, in all domains (sex drive/libido, erectile function, ejaculatory function, level of bother). Regression analysis revealed significant association between increased total BMSFI score and increased TT levels at six months.

"In hypogonadal patients, 12-month administration of topical testosterone gel resulted in increased TT and FT levels and significantly improved sexual function," the authors write.

All of the study authors disclosed financial ties to the pharmaceutical industry, including Auxilium Pharmaceuticals, which funded the TRiUS registry, which partially funded the study.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.


Previous: Donor-Specific Antibody Tied to Renal Graft Rejection Risk Next: Sarcoma Characteristics ID'd in TP53 Mutation Carriers

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.